Eli Lilly has an oral medication under FDA review expected in 2026, but Novo Nordisk's oral Wegovy is currently the only approved oral option
Insulin resistance may contribute to long-term weight gain
Do not take a larger or smaller dose or take the medicine more or less frequently than prescribed
Overweight, obesity, and blood pressure: the effects of modest weight reduction
Irreversible: Unlike stopping a medication, the changes from surgery are permanent (this is also a pro) Conclusion: Many turn to Ozempic hoping for a miracle, but often are disappointed when the expected weight loss doesnt happen
70 (Supplement_1): 106OR [31] Innovent Biologics Clinical Data Update Mazdutide (IBI362) Higher Dose 9mg Phase 2 Clinical study in obesity, May 11, 2023